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COMMENTARY
We are not alone: a case for the human 
microbiome in extra intestinal diseases
S. Shivaji*
Abstract 
Background: “Dysbiosis” in the gut microbiome has been implicated in auto-immune diseases, in inflammatory dis-
eases, in some cancers and mental disorders. The challenge is to unravel the cellular and molecular basis of dysbiosis 
so as to understand the disease manifestation.
Main body: Next generation sequencing and genome enabled technologies have led to the establishment of the 
composition of gut microbiomes and established that “dysbiosis” is the cause of several diseases. In a few cases the 
cellular and molecular changes accompanying dysbiosis have been investigated and correlated with the disease. Gut 
microbiome studies have indicated that Christensenella minuta controls obesity in mice, Faecalibacterium prausnitzii 
protects mice against intestinal inflammation and Akkermansia muciniphila reverses obesity and insulin resistance by 
secreting endocannabinoids. In mice polysaccharide antigen A on the surface of Bacteroides fragilis, reduces inflam-
mation. Such experiments provide the link between the gut microbiome and human health but implicating dysbiosis 
with extra-intestinal diseases like arthritis, muscular dystrophy, vaginosis, fibromyalgia, some cancers and mental 
disorders appears to be more challenging. The relevance of gut microbiome to the eye appears to be very remote. 
But considering that the eye is the site of inflammatory diseases like uveitis, scleritis, Mooren’s corneal ulcer etc. it is 
possible that these diseases are also influenced by dysbiosis. In mice signals from the gut microbiota activate retina 
specific T cells that are involved in autoimmune uveitis. Such information would open up new strategies for therapy 
where the emphasis would be on restoring the diversity in the gut by antibiotic or specific drug use, specific microbe 
introduction, probiotic use and fecal transplant therapy. The ocular surface microbiome may also be responsible for 
eye diseases in man but such studies are lacking. Microbiome of the healthy cornea and conjunctiva have been iden-
tified. But whether the ocular microbiome exhibits dysbiosis with disease? Whether ocular microbiome is influenced 
by the gut microbiome? What mediates the cross-talk between the gut and ocular microbiomes? These are questions 
that need to be addressed to understand idiopathic infections of the eye.
Conclusions: Evaluating diseases remote from the gut would unfold the mysteries of the microbiome.
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Background
The only time we are alone is prior to birth. Then onwards 
we are colonized by innumerable number of bacteria 
acquired from the mother and the environment and by 
adulthood we have trillions of bacteria colonizing every 
surface of the body. In the adult gut the number increases 
to 1014 bacteria which weighs around 1.13 kg and is ten 
times more than the total number of cells in the human 
body (1013). Thus we are more bacteria than human. This 
enormous community of microorganisms was termed 
the “microbiome” by Lederberg and Mccray [1] and was 
defined as a multi-species community of microorganisms 
(bacteria, fungi and viruses) that differs from niche to 
niche in population density and community composition. 
For instance the microbiome of the gut is different from 
that on the skin, on the scalp, inside the nostrils, mouth, 
armpits, oesophagus, stomach, small intestine, vagina 
etc. [2–4]. What could be the reasons for the variation? 
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How is it important? And what is the role of genes associ-
ated with the microbiome which according to conserva-
tive estimates is 200–300 times more than the total genes 
in the human body? These are few of the questions that 
need to be answered.
Main text
Dysbiosis and diseases
Till the 1990s, it has been a mystery as to whether the 
microbes/genes in the gut microbiome have any impact 
on human health other than the canonical role of the 
gut bacteria to break down food remnants, modulate 
the immune system, promote fat storage, biosynthesis of 
vitamins and amino acids, metabolism of drugs etc. But, 
with the advent of next generation sequencing and other 
genome enabled technologies including DNA based data-
bases and metabolomics on human microbiome stud-
ies have become an eye-opener to hitherto unknown 
facts about the composition of gut microbiomes, their 
dynamics and their relevance to human welfare [5]. At 
the phylum level Bacteroidetes and Firmicutes are the 
most dominant bacteria in the gut of normal individu-
als and together constitute 70–90% of the total bacterial 
community followed by Actinobacteria and Proteobac-
teria. This community is dynamic and known to vary in 
normal individuals with age, ethnicity, diet, exposure to 
chemicals and also host genetic variation [6–9]. Studies 
analyzing the gut microbiomes of twins established a link 
between human genotype and the composition of the gut 
microbiome [7]. All these factors make the very definition 
of a normal core microbiome a great challenge. Aberra-
tions from the normal core microbiome is referred to as 
“dysbiosis” (meaning imbalance in the microbiome) and 
has been implicated in auto-immune diseases like diabe-
tes, rheumatoid arthritis, muscular dystrophy, multiple 
sclerosis and fibromyalgia, in inflammatory diseases like 
obesity, neonatal necrotizing enterocolitis, inflammatory 
bowel disease and vaginosis, in some cancers and mental 
disorders [10, 11]. Ability of the gut microbiome to mod-
ulate the immune system is considered as an important 
reason for the diseased state [12]. The direct evidence 
that the microbiota are indeed the cause of the disease 
is strengthened by the pioneering studies on obesity in 
mice. Gut bacteria from fat mice when transplanted into 
genetically lean mice with no gut bacteria of their own, 
transform the lean mice into obese mice [13, 14]. Subse-
quent studies demonstrated that skinny germ free mice 
plump up on receiving a fecal transplant from a human 
donor implying that the bacteria help the recipient to 
digest and metabolise more efficiently [13–15]. But, if the 
fecal transplant of the human donor was supplemented 
with Christensenella minuta the recipient mice were 
thinner indicating that C. minuta controls obesity [7]. 
Another example, emphasizing the role of gut bacteria 
is related to Clostridium difficile infection (CDI) patients 
who are cured of CDI when transplanted with fecal 
microbiota from normal individuals [16, 17]. This led to 
the concept that just as a pathogen could cause a disease 
a “good” microbe could prevent a disease? For instance 
Faecalibacterium prausnitzii could protect mice against 
experimentally induced intestinal inflammation since 
these gut bacteria were anti-inflammatory. Yet another 
example of a good microbe is Akkermansia muciniphila. 
Increase in abundance of A. muciniphila correlated with 
an improved metabolic profile and reversed obesity and 
decreased insulin resistance probably mediated by endo-
cannabinoids secreted by A. muciniphila [18, 19].
Dysbiosis and extra‑intestinal diseases
Linking food/gut related disease like obesity, inflamma-
tory bowel disease, enterocolitis, diabetes etc. to dys-
biosis appears to be obvious but implicating dysbiosis 
with extra-intestinal diseases like arthritis, muscular 
dystrophy, multiple sclerosis, vaginosis, fibromyalgia, 
some cancers and mental disorders appears to be more 
challenging. These studies indicate that the microbi-
ome has an overarching influence on human health. For 
instance it was demonstrated that transplanting a spe-
cific combination of fecal bacteria into the gut of normal 
mice rendered them depressed due to changes in the 
“myelin” sheath that surrounds nerve fibers [20]. Cresol, 
produced by certain gut bacteria and which reduces the 
amount of myelin produced by brain cells was higher in 
mice that became depressed after fecal transplants. It 
was also observed that in mice modeled on two inflam-
matory human diseases: colitis and multiple sclerosis, 
polysaccharide antigen A (PSA) on the surface of the 
gut microbe Bacteroides fragilis, regulates immunity and 
reduces inflammation [21]. Experiments which produce 
such leads at the molecular level would help to under-
stand the link between the gut and human health irre-
spective of the site of pathology and may thus provide 
leads for therapy.
Dysbiosis and ocular diseases
The relevance of gut microbiome to the eye appears to 
be very remote. But considering that the eye is the site 
of inflammatory diseases like uveitis, scleritis, Mooren’s 
corneal ulcer etc. which also occur due to autoimmune 
reaction, it is possible that under non-infectious condi-
tions these diseases are influenced by dysbiosis in the gut. 
Last year it was demonstrated that in mice with experi-
mentally induced autoimmune uveitis oral administra-
tion of antibiotics reduced the severity of uveitis [22]. 
But, intraperitoneal administration of the same antibiotic 
did not have the desired effect thus highlighting the role 
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of gut microbiota in affecting uveitis. Simultaneously, it 
was also observed that the gut microbiome was signifi-
cantly altered following antibiotic administration. Thus 
implying that uveitogenic bacteria may exist, and some 
antibiotics may be able to alter the balance of microbiota 
in favour of protective bacteria and thus help to resolve 
uveitis. Such studies could form the basis for therapeutic 
modulation of diseases. In a recent study, in mice, it was 
demonstrated that signals from the gut microbiota acti-
vate retina specific T cells that are involved in autoim-
mune uveitis [23]. Such information would open up new 
strategies for therapy were the emphasis would be on 
restoring the diversity in the gut by antibiotic or specific 
drug use, by specific microbe introduction, by probiotic 
use and by fecal transplant therapy.
Ocular surface microbiome may also be responsi-
ble for eye diseases in man. Dong et al. [24] studied the 
microbiome of the healthy cornea and conjunctiva of 
four individuals and identified a core microbiome of 12 
genera which included commensal, environmental, and 
opportunistic pathogenic bacteria. Whether the ocular 
microbiome exhibits dysbiosis with disease? Whether 
ocular microbiome is influenced by the gut microbiome? 
What mediates the cross-talk between the gut and ocu-
lar microbiomes? These are questions that need to be 
addressed to understand idiopathic infections of the eye. 
Research directed on the above lines would help to estab-
lish whether the gut microbiome influences ocular sur-
face disease directly or indirectly by altering the ocular 
microbiome and probably also help to identify the causa-
tive organism.
Conclusions
What seems to be amiss in these studies is an over 
emphasis on establishing core microbiomes rather than 
trying to ascertain the reasons for dysbiosis and meth-
ods to overcome dysbiosis. Further attempts to get at the 
relevance of dysbiosis by manipulating the microbiomes 
or by animals studies is also limiting. Above all, work 
on bacterial communities far outpaces that of viral and 
eukaryotic communities, although these agents are resi-
dent in the gut and could be the cause of several diseases. 
Finally evaluating diseases remote from the gut such as 
the eye, brain, kidney etc. would unfold the mysteries of 
the new organ the “microbiome”. It is only future studies 
that would either prove or disprove what Cho and Blaser 
[4] have said “—this (microbiome) is a frontier for human 
preventive medicine and for medical management of 
chronic diseases”.
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